Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MORISHITA SEIYAKU KK
Ajinomoto Co Inc
Morishita Pharmaceuticals Co Ltd
Original Assignee
MORISHITA SEIYAKU KK
Ajinomoto Co Inc
Morishita Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MORISHITA SEIYAKU KK, Ajinomoto Co Inc, Morishita Pharmaceuticals Co LtdfiledCriticalMORISHITA SEIYAKU KK
Priority to JP4061979ApriorityCriticalpatent/JPS55133313A/en
Publication of JPS55133313ApublicationCriticalpatent/JPS55133313A/en
PURPOSE: A high-safety cholesterol-lowering agent that contains 3aα-H-4α-[3'- propionic acid]-5α-hydroxy-7aβ-methylhezahydro-1-indanone-δ-lactone.
CONSTITUTION: 3aα-H-4α-[ 3'-propinonic acid ]-5α-hydroxy-7aβ-methylhexahydro-1-indanone-δ-lactone (abbreviated to HIL) is prepared to oral drags such as paste, granules, tablets, capsules or injection form and used to lower cholesterol. HIL is a high-safety substance and the acute toxicity is larger than 300 (LD50mg/kg) in orally administered mice.